In this section, we will focus particularly on the hypothalamic neuropeptide oxytocin and the pituitary-derived hormone prolactin, as these hormones have been reported to play a modulating role in migraine, contributing to its sex-dimorphism, and offer potential therapies targeting these hormones or their receptors. This evidence concerns the gene OXT and migraine disorder.